Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma

F Palmerini1, E Devilard, A Jarry

  • 1INSERM U 119; Department of Pathology, Institut Paoli-Calmettes, IFR 57 and Université de la Méditerranée, Marseille, France.

Human Pathology
|May 31, 2001
PubMed

Insights

Colon cancer cells show reduced levels of caspase 7 and caspase 9. Restoring caspase 7 function may offer a new therapeutic strategy for colon neoplasia.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Death Research

Background:

  • Caspases are key executioners of apoptosis.
  • Their role in cancer development, particularly colon cancer, requires further investigation.
  • Understanding caspase expression and function is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the expression and functional role of caspases 7, 8, and 9 in colon cancer.
  • To determine if caspase expression differs between colon cancer tissues and normal tissues.
  • To explore the involvement of caspases in apoptosis induction in colon cancer cell lines.

Main Methods:

  • Immunohistochemistry (IHC) was used to assess caspase expression in colon cancer tissues and adjacent normal mucosa.
  • Western blot analysis was performed on colon cancer cell lines (HT29-19A, HT29-16E).
  • Apoptosis was induced using staurosporine, and caspase processing was analyzed in the presence and absence of a caspase inhibitor (ZVAD).

Main Results:

  • Downregulation of caspase 7 and caspase 9 was observed in colon cancer tissues compared to normal mucosa.
  • Caspase 8 expression remained largely unchanged or was slightly upregulated.
  • Staurosporine-induced apoptosis in colon cancer cell lines involved the processing of caspases 3, 7, 8, and 9, and was sensitive to caspase inhibition.

Conclusions:

  • Human colon cancer cells exhibit reduced expression of caspase 7 and, to a lesser extent, caspase 9.
  • In vitro apoptosis induction in colon cancer cells is mediated by caspases 7 and 9.
  • Caspase 7 deficiency may serve as a novel immunohistochemical marker for colonic neoplasia, and its restoration could be a therapeutic target.